Ex-Vivo Expanded Allogeneic γδT Cell Therapy (Chinese Academy Of Medical Sciences)

N/A

Report date: 2024/11/23 20:00:08

Base Information

Drug NameEx-Vivo Expanded Allogeneic γδT Cell Therapy (Chinese Academy Of Medical Sciences)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaPending

Originator CompaniesNo 302 Hospital Of The People Liberation Army Of China

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNo 302 Hospital Of The People Liberation Army Of China

Active IndicationsN/A

Inactive IndicationsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A